STOCK TITAN

International Flavors&Fragranc - IFF STOCK NEWS

Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.

Overview of International Flavors & Fragrances Inc. (IFF)

International Flavors & Fragrances Inc. (IFF) is a global leader in the creation and supply of flavors, fragrances, and specialty ingredients. Operating at the intersection of science, creativity, and innovation, IFF serves a wide range of industries, including food and beverages, personal care, household goods, pharmaceuticals, and biotechnology. With a legacy of innovation and a commitment to delivering sensorial experiences, IFF collaborates with customers to co-create solutions that enhance everyday products and improve consumer experiences.

Business Segments and Operations

IFF operates through four primary business divisions:

  • Nourish: This segment focuses on providing flavors, food ingredients, and texturants. It is a leader in plant-based proteins and innovative solutions like enzymatic texturizing technologies, which enhance the sensory and functional qualities of food and beverages.
  • Scent: IFF is one of the world’s leading producers of fragrances for fine perfumes, beauty products, and home care items. Leveraging advanced research and consumer insights, the Scent division creates tailored solutions that resonate with diverse cultural and regional preferences.
  • Health & Biosciences: This division specializes in probiotics, enzymes, and microbiome solutions. It serves industries like animal nutrition, biofuel production, and dietary supplements, using cutting-edge technologies to address complex challenges such as gut health and low-carbon ethanol production.
  • Pharma Solutions: With over 75 years of expertise, this segment provides excipients and biopolymers for the pharmaceutical and biotech industries. Its innovations include low nitrite excipients and ultrapure alginate technologies for advanced drug delivery systems.

Market Position and Competitive Landscape

IFF holds a unique position in the specialty ingredients market, blending scientific precision with creative artistry. It is recognized as a major player in flavors, fragrances, and health-focused biosciences. The company differentiates itself through its robust research and development capabilities, global scale, and ability to co-create customized solutions with its clients. Competitors include Givaudan, Symrise, and Firmenich, but IFF’s diversified portfolio and technological advancements provide a competitive edge.

Innovative Technologies and Capabilities

Innovation is at the core of IFF’s operations. The company employs advanced technologies like artificial intelligence, enzymatic solutions, and nutribiosis—a concept that integrates nutrition, microbiome, gut health, and immune function. Recent innovations include AI-powered tools for fragrance development and enzymatic solutions for improving food textures and ethanol production efficiency. These technologies not only enhance product quality but also address sustainability goals, such as reducing greenhouse gas emissions and improving resource efficiency.

Global Reach and Customer-Centric Approach

With a presence in over 100 countries, IFF collaborates closely with its customers to understand regional preferences and market trends. Its customer-centric approach is evident in initiatives like the China Scent Exploration Program and the launch of digital platforms like AnswerCenter, which streamline access to technical information and solutions.

Conclusion

International Flavors & Fragrances Inc. exemplifies the fusion of science and creativity to deliver innovative solutions across diverse industries. Through its commitment to research, customer collaboration, and technological advancement, IFF continues to shape the future of flavors, fragrances, and specialty ingredients, making it a cornerstone in its industry.

Rhea-AI Summary

On July 28, 2022, IFF announced a significant investment of $15.8 million in three innovation centers located in Latin America: Sao Paulo (Brazil), Bogota (Colombia), and Santiago (Chile). These state-of-the-art facilities enhance R&D capabilities across IFF's divisions, including Nourish, Health & Biosciences, and Scent. The new centers aim to foster collaboration and accelerate product development, serving diverse sectors such as food, beverage, and health. This investment aligns with IFF's strategy to leverage the growth potential of the Latin American market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
none
-
Rhea-AI Summary

IFF (NYSE: IFF) will release its second quarter 2022 earnings results after the market closes on August 8, 2022. A live webcast will follow on August 9, 2022 at 9:00 a.m. ET for management to discuss the results and outlook. Investors can access the webcast and presentation on the company’s website, with a replay available for those who miss the live event. IFF is a leader in food, beverage, health, biosciences, and scent, creating innovative solutions through science and creativity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
none
-
Rhea-AI Summary

IFF has appointed Nicolas Gebara as the new senior vice president of Commercial and Flavors for its Nourish division, effective July 1, 2022. Gebara, who has 23 years of experience at IFF, will streamline flavors and global sales to better meet consumer demands. The organizational adjustments also include new roles for Carmen Cain, Brian Brix, and Jan Bechtel, aimed at optimizing customer experience and enhancing business operations. IFF's Nourish division remains a leader in high-value categories despite current market challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.3%
Tags
management
Rhea-AI Summary

IFF (NYSE:IFF) has successfully completed the divestiture of its Microbial Control business unit to LANXESS. This strategic move is part of IFF's ongoing efforts to streamline its operations and focus on core areas of business, which include food, beverage, health, biosciences, and scent. The company aims to leverage science and creativity to create innovative solutions for a sustainable future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
none
-
Rhea-AI Summary

On June 14, 2022, IFF launched its new GUARDIAN® product family, focusing on plant extract-based formulations for oxidation control in food and beverages. The global food antioxidant market is expected to reach USD 1.8 billion by 2025, driven by demand for packaged food and clean ingredients. GUARDIAN® SYNEROX HT can reduce frying oil waste by 30%, while GUARDIAN® VITAGREEN LOD employs innovative technology for incorporating green tea extract. These solutions aim to enhance food quality, safety, and sustainability, addressing supply chain challenges and reducing food waste.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
Rhea-AI Summary

IFF (NYSE: IFF) announced that CEO Frank Clyburn will participate in a fireside chat at the Bernstein 2022 Strategic Decisions Conference on June 1, 2022, at 8 am ET. Investors can access the live webcast through the company's website at ir.iff.com. A recorded version will also be available for replay.

IFF is a leader in food, beverage, scent, health, and biosciences, providing essential solutions for global markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
conferences
-
News
Rhea-AI Summary

International Flavors & Fragrances reported strong first quarter 2022 results with net sales of $3.23 billion, marking a 31% increase year-over-year. Adjusted operating EBITDA increased to $702 million, up 23% from the previous year. CEO Frank Clyburn highlighted growth across all segments, particularly in Nourish, Health & Biosciences, and Pharma Solutions. The company raised its full-year sales forecast to $12.6-$13.0 billion, anticipating continued growth despite inflationary pressures. However, a negative currency impact is expected to reduce sales and EBITDA growth by approximately 4% and 5%, respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.03%
Tags
none
-
Rhea-AI Summary

IFF (NYSE: IFF) has declared a quarterly cash dividend of $0.79 per share, set to be paid on July 6, 2022, to shareholders on record by June 24, 2022. This announcement underscores IFF's commitment to returning value to its investors. The company continues to lead in food, beverage, scent, health, and biosciences, offering innovative solutions and experiences. IFF aims to combine art and science to meet global consumer demands while promoting sustainability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
dividends
Rhea-AI Summary

On May 3, 2022, IFF announced its expanded portfolio of nutritional ingredients and supplements ahead of Vitafoods Europe, taking place from May 10-12. The showcase will highlight their capabilities in botanicals and plant-based applications. Notable offerings include new probiotic combinations for women's health and innovative, sustainable supplements like GRINDSTED® Pectin PRM. IFF also emphasizes advancements in taste-masking bitter botanicals and novel delivery formats. The company aims to assist supplement manufacturers in developing high-quality products that meet evolving consumer demands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none

FAQ

What is the current stock price of International Flavors&Fragranc (IFF)?

The current stock price of International Flavors&Fragranc (IFF) is $81.81 as of February 28, 2025.

What is the market cap of International Flavors&Fragranc (IFF)?

The market cap of International Flavors&Fragranc (IFF) is approximately 20.7B.

What industries does International Flavors & Fragrances (IFF) serve?

IFF serves industries such as food and beverages, personal care, household goods, pharmaceuticals, and biotechnology, providing innovative flavors, fragrances, and specialty ingredients.

What are the main business segments of IFF?

IFF operates through four key segments: Nourish, Scent, Health & Biosciences, and Pharma Solutions, each catering to specific industry needs.

How does IFF differentiate itself from competitors?

IFF stands out through its robust research and development, advanced technologies like AI and enzymatic solutions, and its ability to co-create customized products with clients.

What is nutribiosis, and how is IFF involved in it?

Nutribiosis is the interplay between nutrition, microbiome, gut health, and immune function. IFF applies this concept in its Health & Biosciences division to develop innovative solutions for animal and human health.

What recent innovations has IFF introduced?

Recent innovations include AI-powered tools for fragrance development, enzymatic solutions for food texture enhancement, and low-carbon ethanol production technologies.

What role does IFF play in the pharmaceutical industry?

IFF’s Pharma Solutions division provides excipients and biopolymers for drug delivery systems, focusing on innovations like low nitrite excipients and ultrapure alginate technologies.

Where is IFF headquartered, and what is its global reach?

IFF is headquartered in New York and has a presence in over 100 countries, serving a diverse range of global markets.

What is IFF’s approach to sustainability?

IFF integrates sustainability into its operations by developing solutions that reduce greenhouse gas emissions, improve resource efficiency, and support environmentally friendly practices.

Who are IFF’s main competitors?

IFF competes with companies like Givaudan, Symrise, and Firmenich in the flavors, fragrances, and specialty ingredients market.

What is the significance of IFF’s customer-centric initiatives?

IFF’s customer-centric initiatives, such as the China Scent Exploration Program and the AnswerCenter platform, enhance collaboration, streamline access to solutions, and address regional market needs effectively.
International Flavors&Fragranc

NYSE:IFF

IFF Rankings

IFF Stock Data

20.72B
255.32M
0.06%
94.2%
1.89%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States
NEW YORK